Viz HCM vs Viz RV/LV

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Viz.ai
VS
by Viz.ai

AI Verdict

Both Viz HCM and Viz RV/LV are FDA-cleared AI tools from Viz.ai designed to enhance care coordination and accelerate time to treatment. While they share a common platform for alerts and workflow integration, they address distinct clinical conditions. Viz HCM focuses on detecting Hypertrophic Cardiomyopathy using ECG analysis, whereas Viz RV/LV automates RV/LV ratio measurements from CTPA scans for pulmonary embolism risk stratification.

Choose Viz HCM if…

Choose Viz HCM if your institution prioritizes early and efficient detection of Hypertrophic Cardiomyopathy (HCM) directly from ECGs. This tool is ideal for cardiology departments and emergency medicine seeking to significantly reduce diagnosis time and automate the coordination of care for suspected HCM patients. It streamlines workflows by providing real-time alerts and directing patients to appropriate specialists.

View Viz HCM →

Choose Viz RV/LV if…

Choose Viz RV/LV if your emergency department or radiology group needs rapid, automated risk stratification for suspected pulmonary embolism (PE) using CTPA scans. This tool is best suited for environments where quick assessment of right ventricular strain is critical for guiding immediate treatment decisions and enhancing care coordination within a broader PE management solution. It provides crucial RV/LV ratio measurements to inform clinical pathways.

View Viz RV/LV →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Viz HCM Viz RV/LV
Deployment Unknown Cloud-based
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Viz RV/LV

Both tools offer seamless integration with existing clinical workflows, EHR, and PACS systems, along with mobile-based alerts for care coordination. However, Viz RV/LV specifically highlights a 'High-fidelity mobile DICOM image viewer' for CTPA scans, which provides a specialized and enhanced user experience crucial for radiologists and emergency physicians reviewing complex imaging on the go.

Clinical Value

Viz HCM

Both are FDA-cleared and clinically validated for critical conditions. Viz HCM addresses Hypertrophic Cardiomyopathy, a condition where nearly 85% of patients are undiagnosed or misdiagnosed, and studies show it significantly reduces diagnosis time from years to a mean of 37 days and identifies new cases years earlier. This profound impact on a largely undiagnosed, life-threatening condition gives it a slight edge in demonstrated clinical value.

Pricing & Value

Viz HCM

Viz HCM offers transparent pricing details, stating it is subscription-based for hospitals and health systems, with CMS reimbursement available for specific CPT codes (0764T and 0765T) effective January 1, 2025, at a national payment rate of $128.90. In contrast, Viz RV/LV's pricing is not publicly available, making it difficult for potential customers to assess its value proposition without direct vendor contact.

Enterprise Readiness

Tie

Both tools are developed by Viz.ai and leverage the same underlying cloud-based platform, ensuring HIPAA compliance, BAA availability, and robust integration capabilities with EHR and PACS systems. Viz.ai's platform is extensively deployed across thousands of hospitals globally, demonstrating proven enterprise-grade security, scalability, and operational rigor for both solutions.

Innovation

Viz HCM

Both tools utilize AI for innovative diagnostic assistance. However, Viz HCM stands out as the first and only FDA-cleared AI algorithm for real-time ECG analysis to detect suspected Hypertrophic Cardiomyopathy, a complex and often missed diagnosis. This application of AI to ECGs for early detection of a historically challenging condition represents a more significant and novel breakthrough.

Support & Docs

Tie

As both tools are products of Viz.ai, they share the same comprehensive customer support infrastructure. Viz.ai provides dedicated customer success teams, clinical and workflow specialists, 24/7 on-call clinical specialists, implementation experts, and a centralized knowledge base with various resources. There is no information to suggest a difference in the level or quality of support and documentation between the two specific tools.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Viz HCM Viz RV/LV
Tool Name Viz HCM Viz RV/LV
Primary Detection Method AI-powered ECG analysis for Hypertrophic Cardiomyopathy (HCM) detection; Real-time disease detection from electrocardiograms AI algorithm for automated Right Ventricle (RV) to Left Ventricle (LV) ratio measurement from CTPA scans; Analysis of volumetric CTPA acquisitions
Target Condition/Measurement Suspected Hypertrophic Cardiomyopathy (HCM) RV/LV ratio for rapid pulmonary embolism risk stratification
Key Specialties Supported Cardiology, Emergency Medicine, Hospital Medicine Emergency Medicine, Pulmonology, Radiology
Care Coordination Features Mobile-based alerts and notifications to multidisciplinary care teams; Automated direction of patients to appropriate care specialists; Streamlines cardiac care coordination and clinical workflows AI-powered alerts and notifications to care teams; HIPAA-compliant communication platform for care coordination
Integration Integrated into hospital IT systems (EHR, PACS); Seamless integration with existing clinical workflows, EHR, and PACS systems Seamless component of the Viz PE Solution
Company Viz.ai Viz.ai

Videos

Demos, reviews, and walkthroughs featuring Viz HCM and Viz RV/LV.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Viz HCM is an AI tool designed for the real-time detection of suspected Hypertrophic Cardiomyopathy (HCM) through ECG analysis. Viz RV/LV, on the other hand, is an AI algorithm that automates right and left ventricular diameter measurements from CTPA scans to aid in rapid pulmonary embolism (PE) risk stratification.
Viz HCM analyzes real-time electrocardiogram (ECG) data to identify patterns suggestive of HCM. In contrast, Viz RV/LV processes volumetric CTPA (Computed Tomography Pulmonary Angiography) acquisitions to measure heart ventricle diameters.
Viz HCM is primarily intended for use in Cardiology, Emergency Medicine, and Hospital Medicine. Viz RV/LV is designed to support specialties such as Emergency Medicine, Pulmonology, and Radiology.
Viz HCM provides AI-powered ECG analysis for HCM detection, real-time mobile alerts to care teams, and automated direction of patients to appropriate specialists. Viz RV/LV automates the measurement of the Right Ventricle (RV) to Left Ventricle (LV) ratio from CTPA scans, provides annotated images showing these measurements, and integrates into the Viz PE Solution for suspected pulmonary embolism detection.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.